Vera Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
Vera Therapeutics Current Ratio Growth & History (VERA)
Vera Therapeutics's current ratio was 13.64 for fiscal 2025.
View full Vera Therapeutics company overviewVera Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 13.64 | −12.03 | −46.88% |
| 2024 | 2024-12-31 | 25.67 | 17.95 | +232.79% |
| 2023 | 2023-12-31 | 7.71 | 2.80 | +57.09% |
| 2022 | 2022-12-31 | 4.91 | −5.82 | −54.25% |
| 2021 | 2021-12-31 | 10.73 | −11.82 | −52.41% |
| 2020 | 2020-12-31 | 22.55 | — | — |
Vera Therapeutics quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 10.92 | −6.11 | −35.89% |
| Q1 2026 | 2026-03-31 | 13.64 | −14.04 | −50.73% |
| Q4 2025 | 2025-12-31 | 13.64 | −12.03 | −46.88% |
| Q3 2025 | 2025-09-30 | 12.21 | −1.55 | −11.27% |
| Q2 2025 | 2025-06-30 | 17.03 | −4.40 | −20.55% |
| Q1 2025 | 2025-03-31 | 27.68 | −0.95 | −3.31% |
| Q4 2024 | 2024-12-31 | 25.67 | 17.95 | +232.79% |
| Q3 2024 | 2024-09-30 | 13.76 | 6.79 | +97.40% |
| Q2 2024 | 2024-06-30 | 21.43 | 14.33 | +201.73% |
| Q1 2024 | 2024-03-31 | 28.63 | 19.94 | +229.49% |
| Q4 2023 | 2023-12-31 | 7.71 | 2.80 | +57.09% |
| Q3 2023 | 2023-09-30 | 6.97 | −0.88 | −11.21% |
| Q2 2023 | 2023-06-30 | 7.10 | −1.13 | −13.77% |
| Q1 2023 | 2023-03-31 | 8.69 | 0.79 | +10.00% |
| Q4 2022 | 2022-12-31 | 4.91 | −5.82 | −54.25% |
| Q3 2022 | 2022-09-30 | 7.85 | −14.36 | −64.65% |
| Q2 2022 | 2022-06-30 | 8.24 | −17.19 | −67.60% |
| Q1 2022 | 2022-03-31 | 7.90 | −5.83 | −42.47% |
| Q4 2021 | 2021-12-31 | 10.73 | −11.82 | −52.41% |
| Q3 2021 | 2021-09-30 | 22.21 | — | — |
| Q2 2021 | 2021-06-30 | 25.42 | — | — |
| Q1 2021 | 2021-03-31 | 13.73 | — | — |
| Q4 2020 | 2020-12-31 | 22.55 | — | — |
Vera Therapeutics current ratio trends
Over the last five fiscal years, Vera Therapeutics's current ratio decreased from 22.55 to 13.64, a change of −8.92. The latest reported quarter, Q2 2026, shows 10.92.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vera Therapeutics source filings ↗